S5 - E7.2 - Identifying the target MASH patients for Rezdiffra
Send us Fan Mail This conversation focuses on two issues: (i) identifying the right target MASH patients for Rezdiffra, and (ii) the extensive Madrigal patient support program for Rezdiffra. It start...
23 Mars 20249min
S5 - E7 - MASLD Patient Advocates Celebrate Rezdiffra and Discuss the Future
Send us Fan Mail Last Thursday, March 14, Rezdiffra (resmetirom) became the first drug approved in the US for MASH. Five leading North American MASLD patient advocates join the Surfers to discuss thei...
21 Mars 20241h 5min
S5 - E6.6 - Closing Question From The Episode On Rezdiffra, The First MASH Drug
Send us Fan Mail As the conversation wound down, Roger Green offered panelists to address any issue pertaining to Rezdiffra, the first MASH drug, that had not come up in the hour-long conversation. ...
19 Mars 20248min
S5 - E6.5 - BioPharma Industry Takeaways ForBioPharma Industry Takeaways From The Rezdiffra Launch The Rezdiffra Launch
Send us Fan Mail This conversation revolves around one question: "What lessons should the BioPharma industry take from the launch of Rezdiffra?" Answers revolve largely around clinical trial design an...
19 Mars 20247min
S5 - E6.4 - Finding The MASH Patients That Are The Initial Rezdiffra Targets
Send us Fan Mail One pivotal question surrounding the launch of Rezdiffra is "Which MASH patients are the correct targets for the first MASH drug?" This conversation focuses on the tools and education...
19 Mars 202412min
S5 - E6.3 - Staging and screening patients for Rezdiffra using NITs
Send us Fan Mail This conversation focuses on the necessity of using NITs to screen and identify Rezdiffra patients, while at the same time acknowledging the shortcomings of current tests. Panelists s...
18 Mars 202415min
S5 - E6.2 - How Approval Of Rezdiffra,The First MASH Drug, Might Improve Patient Adherence To Lifestyle Recommendations
Send us Fan Mail This conversation focuses on what panelists see as a key (and somewhat unusual) benefit of Rezdiffra: that having a prescription drug for MASH creates a better environment for discuss...
18 Mars 202411min
S5 - E6.1 - Rezdiffra Is Approved! How Key Opinion Leaders Processed The News About The First MASH Drug
Send us Fan Mail FDA approval of the first MASH drug, Rezdiffra, on March 14 marked what co-host and Key Opinion Leader Jörn Schattenberg describes as a "watershed moment" for hepatology. This opening...
18 Mars 202411min
